Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The company’s IPO filing came a day after Parabilis inked an up-to-$2.3 billion-...
In this episode of GEN's Touching Base, editors celebrate the 50th episode. They...
This Sunday, a group of 42 athletes will gather in Las Vegas to compete in a som...
New AI‑designed miniproteins precisely modulate GPCR signaling and reveal a new ...
In addition to producing pDNA, RNA, and LNP formulations, Wacker’s CRS team offe...
Scientists developed a cytokine-armored CAR T-cell therapy that helps the immune...
Scientists created an AI tool that can help to reveal how genes function togethe...
Breaking from the traditional plenary format, Bio-IT World Conference 2026 opene...
Boyang Wang, founder and CEO of Immortal Dragons, focuses on longevity-driven or...
End-to-end fermentation training for students and new hires cost-effectively rei...
The diversity of materials and manufacturing methods used to make cell therapies...
Mutations engineered into antibodies could help companies developing the next ge...
A new AI-driven framework enables highly accurate prediction of RNA splicing and...
CDD and Lilly say their agreement paves the way for the planned integration of L...
CEO Tomoyuki Hasegawa discusses the vast potential of stem cells and the company...
Regeneron will marry its antibody capabilities with Parabilis’ stabilized helica...
